AC Immune Reports Interim Results From Phase 2 Trial of ACI-7104.056

Yahoo FinanceNov 15 20:30

HC Wainwright & Co. Reiterates Buy on AC Immune, Maintains $16 Price Target

BenzingaNov 15 19:39 · Ratings

Promising Interim Data and Safety Profile Justify Buy Rating for AC Immune's ACI-7104.056 Vaccine Trial

TipRanksNov 15 19:35 · Ratings

AC Immune Stock Jumps 20% on Data for Parkinson's Disease Drug

Seeking AlphaNov 15 03:51

S&P 500 Moves Lower; US Crude Oil Inventories Increase

BenzingaNov 15 03:08

Sector Update: Health Care Stocks Lower Thursday Afternoon

MT NewswiresNov 15 02:53